Cell and Tissue Engineering

We use the techniques of protein chemistry, molecular genetics, biophysics and cell biology. Centered on membrane proteins, we investigate both their fundamental properties and their applications in biotechnology.

We investigate the mechanisms of interaction between biological and synthetic materials to design and engineer new systems for treating diseases such as cancer, chronic infections and neurological disorders.

The biomedical ultrasonics, biotherapy and biopharmaceuticals laboratory (BUBBL) investigate mechanisms that simultaneously enhance non-invasive therapy and enable real-time monitoring and control of the therapeutic process deep within the body.

We study carbohydrate and protein functions using organic synthesis and protein engineering. We aim to design and modify therapeutic and biotechnological systems, uncover biological mechanisms, and develop new tools for synthetic and chemical biology.

We use mathematical modelling and mechanics to explore morphogenesis, growth, diseases with a special emphasis on plants and the brain.

T cells initiate immune responses to clear infections and cancers. They integrate signals from various surface receptors using intracellular signalling molecules. We use quantitative methods to understand this process and enhance human health.

Our research balances the investigation of fundamental science with the development of technologies and designer biomaterials to address some of the major healthcare challenges across diagnostics, advanced therapeutics and regenerative medicine.

We focus on providing enabling technologies for regenerative medicine, including industrial scale cell/tissue culture in vitro, implantable biomaterials and processing, bio-manufacture of cellular therapeutics, and supply chain of living cells and tissues